THE healthcare arm of Ayala Corp., Ayala Healthcare Holdings Inc. (AC Health), announced it plans to deepen its presence in key urban centers, including Cebu, as it charts an ambitious roadmap to become a $2 billion healthcare enterprise by 2035.
The expansion is part of a broader strategy unveiled as the company marks its 10th anniversary this year, aiming to scale its integrated network of hospitals, clinics and pharmacies to serve one in every five Filipinos.
“What we’re building is a healthcare group designed for long haul,” said AC Heath president and chief executive officer Paolo Borromeo. “We are backed by an ecosystem that is rooted in our commitment to providing quality, accessible healthcare for every Filipino.”
The company said it will pursue both organic and inorganic growth to expand its hospital and clinic footprint across the country, particularly in high-growth areas like Cebu. It also plans to grow its pharmaceutical retail business nationwide through a multi-brand approach.
AC Health has grown from a single investment in Generika Drugstore in 2015 into an integrated network that includes: 236 corporate and multispecialty clinics, and six hospitals under the Healthway Medical Network; 880 pharmacies under Generika and St. Joseph Drug; and 1,178 certificates of product registration under pharma units I.E. Medica and MedEthix.
AC Health’s revenues rose 10 percent to P9.4 billion in 2024. Its provider group, Healthway Medical Network, posted 22 percent revenue growth—outpacing the hospital industry average of eight percent. Meanwhile, its pharma business outperformed the broader sector, which contracted by five percent during the same period.
Looking ahead to 2028, AC Health aims to expand its ecosystem to 1,150 pharmacies, 300 clinics and 10 hospitals.
“Our goal is to build a healthcare company that is not only financially resilient, but also deeply transformative for Filipinos,” Borromeo said. “In 10 years, we’re going to be a $2-billion healthcare enterprise.” / KOC